Answers are grounded in this paper and cite their sources.
A Belgian alpha-1-antitrypsin (AAT) deficiency registry has been established in 2003. Currently 55 patients are included. At the same time, a working group has been set up for publishing national guidelines. In 2014, several Belgian patients founded Alpha-1 Global. We hope that the integrated activities of all the stakeholders involved in AAT deficiency will permit a high quality care for all patients suffering from this disabling disease.
No takes yet. Share an insight, caveat, or question.
Hutsebaut et al. (2015) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: